Michael Weiser - 31 May 2022 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role
Director
Signature
/s/ Michael Weiser
Issuer symbol
IOVA
Transactions as of
31 May 2022
Net transactions value
+$67,978
Form type
4
Filing time
02 Jun 2022, 20:01:53 UTC
Previous filing
01 Jul 2021
Next filing
14 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IOVA Common Stock Purchase $14,850 +2,187 +2.1% $6.79 104,819 31 May 2022 Direct
transaction IOVA Common Stock Purchase $53,128 +7,813 +7.5% $6.80 112,632 31 May 2022 Direct
holding IOVA Common Stock 28,484 31 May 2022 By Actin Capital Partners, LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.